7 Investor presentation First nine months of 2024 Diabetes value market leadership Novo Nordisk global diabetes value market shares 60% 52.2% Diabetes 55.7% GLP-1 Insulin 54.4% 50% 43.4% 43.8% 43.8% 40% 29.7% 30% 31.4% 33.3% 55.6% 43.4% 33.9% 200%% 2021 2022 2023 2024 CER: Constant exchange rates; IO: International Operations; NAO: North America Operations Note: Sales growth rates are at CER Source: IQVIA MAT, Aug 2024 (Spot rate); Volume growth based on Moving Annual Total (MAT); Market values are based on the list
Download PDF file